EXC: Pfizer’s Chief Vaccine Officer Advised US Government On Redrafting Gain Of Function Research Policy.

Contact Your Elected Officials
Bannon's War Room Header

Pfizer’s Chief Scientific Officer for Vaccine Research and Development advised the National Science Advisory Board for Biosecurity during the group’s deliberation over redrafting government policies concerning gain of function research.

The unearthed influence of a leading Pfizer employee over the federal government’s approach to regulating gain of function research, which refers to the manipulation of pathogens to become more lethal, virulent, or transmissible to humans, follows a shocking undercover investigation from Project Veritas into the company. The group caught an employee of the pharmaceutical giant and COVID-19 vaccine maker admitting to engaging in the risky form of research to better profit off vaccines.

In light of these claims, the proximity of Pfizer’s Philip Dormitzer to the U.S. government’s effort to redraft its policies surrounding gain of function research in 2016 is curious, as he was working as the Vice President and Chief Scientific Officer for RNA and Viral Vaccines at Pfizer at the time. He held this position from September 2015 to December 2021.

In 2014, the U.S. government announced a pause on funding gain of function research while concurrently launching a deliberative process to develop a new policy aimed at better regulating the risky form of research.

The two “key voices” engaged in the debate were the National Academies, which convened two symposiums to draft and deliberate gain of function policies, and the National Science Advisory Board for Biosecurity (NSABB). The NSABB was responsible for “providing the U.S. government with recommendations on policy for the funding and conduct of gain of function research” and “serving as the official federal advisory body for providing advice on oversight of this area of dual use research.”

Put simply, the National Academies were the most influential advisor to the NSABB, which, in turn, was responsible drafting the government’s new gain of function research policy.

Among the ten members of the National Academy of Science’s Second Symposium was Dormitzer, whose Pfizer affiliations are clearly displayed on official event documents. The symposium was the final event before the NSABB finalized its draft of recommendations and took place in March 2016.

In other words, the event was highly influential over what the NSABB’s ultimate output regarding gain of function research policy would become.

Dormitzer also served as the moderator of a session titled: “Best Practices to Inform National Policy Design and Implementation: Perspectives of Key Stakeholders in the Biomedical and Public Health Communities.”

“Philip Dormitzer from the Pfizer Vaccine Research and Development Unit and a member of the Symposium Planning Committee, introduced the session as a continuation of the earlier plenary session on the U.S. policy landscape. This session would present the perspectives of several different key stakeholders, including regulatory agencies and the vaccine industry,” explained the National Academy of Science’s breakdown of the event.

Summaries of Dormitzer’s contributions consistently appear to reveal a desire for more lax regulation on gain of function research, with the symposium report noting:

“Philip Dormitzer pointed out that not all GOF research involves GOF studies of concern, and therefore not all the research needs to be overseen by any additional policy frameworks.”

“There was an exploration of the impact of over-regulating GOF research for countermeasure development. Philip Dormitzer pointed out that as one of the factors for identifying GOF studies of concern is the absence of effective countermeasures, limiting research that could provide such measures could be counter-productive. There was also consideration of the opportunity costs of not doing research, especially in justifying potential barriers to developing countermeasures,” added the summary.

He also appeared to express concern over potential “blowback” directed towards vaccines in light of discussions about gain of function research:

“Dormitzer closed with some personal observations. One was an increasing need to consider integration of the multiple biosafety and biosecurity regimens. The other was a concern about unintended consequences, for example from the “blowback” onto vaccine production from the controversies over GOF studies of concern—or GOF research more generally—in academia.”

“Dormitzer closed with some personal observations. One was an increasing need to consider integration of the multiple biosafety and biosecurity regimens. The other was a concern about unintended consequences, for example from the “blowback” onto vaccine production from the controversies over GOF studies of concern—or GOF research more generally—in academia.”

By Natalie Winters

Read Original Article on WarRoom.org

Watch The Project Veritas Video

Bannon's War Room
Bannon's War Roomhttps://warroom.org/
On Bannon's War Room, Steve Bannon brings medical experts, politicians, business leaders and more for a look at the latest news, providing insider insights.

The Choices We Make

Death and disagreement are inevitable. Love and hate are choices. We will all die. Before we do, what choices will we make?

Elon Musk Speaks at Unite the Kingdom Rally

Tommy Robinson held rally, with Elon Musk appearing virtually, calling attention to leftist politicians who allow foreign immigrants to invade England.

Doxed Democrats Are Getting Fired Left and Left

Not a misprint because a title of “left and...

Hold Up, Feds, Without Federalism, There Is No USA

Federalism is essential to governing the U.S., yet the federal government is undermining it by bribing states to implement unnecessary federal programs.

A Widow Inspires The World

Erika Kirk moved the nation with her speech two days after her husband’s assassination, vowing to continue his mission and grow Turning Point USA.

Parents Sue Character.AI for Allegedly Leading Kids to Sexual Abuse, Suicidal Behavior

Parents allege in three lawsuits that Character.AI’s chatbots sexually abused their children and drove them toward suicidal thoughts and behavior.

Tyler Robinson Makes First Appearance in Court, Faces Capital Murder Charge in Charlie Kirk Assassination

Tyler Robinson remained motionless throughout his first court appearance on capital murder and other charges after the shooting death of Charlie Kirk.

Trump to Appeal Ruling Allowing Fed Governor Lisa Cook to Keep Her Job

The Trump admin will appeal a three-judge panel’s ruling that prevents the president from firing Federal Reserve Governor Lisa Cook.

Charlie Kirk’s Alleged Murderer Confessed Shortly After Shooting, Messages Show

The man accused of murdering conservative influencer Charlie Kirk confessed to the killing in text messages, authorities said on Sept. 16.

Rubio Says US Visa Revocations Underway After Charlie Kirk Death Celebrations

SoS Marco Rubio said foreign nationals who made celebratory comments over Charlie Kirk’s assassination will have their U.S. visas revoked.

Trump Supports Designating Antifa a Terrorist Organization

President Trump said he would support designating the antifa movement a terrorist organization in the wake of Charlie Kirk’s assassination last week.

US Conducts Strike on Another Drug Boat From Venezuela: Trump

Three people were killed in a U.S. strike on a Venezuelan drug boat, President Donald Trump announced on Sept. 15.

Trump Signs Memo Targeting Direct-to-Consumer Pharmaceutical Advertising

President Trump signed a memo to ensure drug ads give fair, balanced, and complete information to protect and inform American consumers.
spot_img

Related Articles